Changes of benzodiazepine receptors during chronic benzodiazepine administration in humans

European Journal of Pharmacology

Volumn 368, Issue 2-3, 1999, Pages 161-172

  Fujita, Masahiro ^a   Woods, Scott W ^a   Verhoeff, N Paul L G ^a   Abi Dargham, Anissa ^a   Baldwin, Ronald M ^a   Zoghbi, Sami S ^a   Soares, Jair C ^a   Jatlow, Peter A ^a   Krystal, John H ^a   Rajeevan, Nallakkandi ^a   Charney, Dennis S ^a   Seibyl, John P ^a   Innis, Robert B ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Benzodiazepine; Down regulation; GABA(A) benzodiazepine receptor; Human; SPECT (single photon emission computed tomography)

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; ALPRAZOLAM; BENZODIAZEPINE RECEPTOR; BENZODIAZEPINE RECEPTOR STIMULATING AGENT;

ARTICLE; CONTROLLED STUDY; DRUG TOLERANCE; FEMALE; HUMAN; HUMAN EXPERIMENT; LEARNING; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RECEPTOR DENSITY; RECEPTOR OCCUPANCY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYNAPTIC MEMBRANE;

ADMINISTRATION, ORAL; ADULT; ALPRAZOLAM; ANTI-ANXIETY AGENTS; FEMALE; FLUMAZENIL; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; RECEPTORS, GABA-A; REPRODUCIBILITY OF RESULTS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TREATMENT OUTCOME; VERBAL LEARNING;

EID: 0033012659     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00013-8     Document Type: Article

References (57)

1. 123I ]iomazenil: kinetic and equilibrium paradigms J. Nucl. Med. 35:1994;228-238.
2. Ballenger J.C., Burrows G.D., DuPont R.L., Lesser I.M., Noyers R., Pecknold J.C., Rifkin A., Swinson R.P. Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. Arch. Gen. Psychiatry. 45:1988;292-298.
3. A receptors. Int. Rev. Neurobiol. 39:1996;53-76.
4. A receptors. J. Recept. Signal Transduction Res. 17:1997;99-113.
5. Brandt J. The Hopkins Verbal Learning Test: development of a new memory test with six equivalent forms. Clin. Neuropsychol. 5:1991;125-142.
6. Bremner, J.D., Bronen, R.A., De Erasquin, G., Vermetten, E., Staib, L.H., Ng, C.K., Soufer, R., Charney, D.S., Innis, R.B., in press. Anatomically defined brain regions of interest based on PET-MRI coregistration: development, rationale, and reliability of method. Clin. Positron Imaging.
7. 3H ]flunitrazepam binding after chronic low dose diazepam treatment in rats Proc. Br. J. Pharmacol. 105:1992;172P.
8. Buchel C., Wise R.J.S., Mummery C.J., Poline J.-B., Friston K.J. Nonlinear regression in parametric activation studies. Neuroimage. 4:1996;60-66.
9. Byrnes J.J., Miller L.G., Greenblatt D.J., Shader R.I. Chronic benzodiazepine administration: XII. Anticonvulsant cross-tolerance but distinct neurochemical effects of alprazolam and lorazepam. Psychopharmacology. 111:1993;91-95.
10. 18F ]cyclofoxy and positron emission tomography J. Cereb. Blood Flow Metab. 13:1993;24-42.
11. Ciraulo C., Barnhill J.G., Boxenbaum H.G., Greenblatt D.J., Smith R.B. Pharmacokinetics and clinical effects of alprazolam following single and multiple oral doses in patients with panic disorder. J. Clin. Pharmacol. 26:1986;292-298.
12. 123I ]iomazenil J. Nucl. Med. 35:1994;399-404.
13. Feighner J.P., Aden G.C., Fabre L.F., Rickels K., Smith W.T. Comparison of alprazolam, imipramine and placebo in the treatment of depression. JAMA. 249:1983;3057-3064.
14. Friedman H., Abernethy D.R., Greenblatt D.J., Shader R.I. The pharmacokinetics of diazepam and desmethyldiazepam in rat brain and plasma. Psychopharmacology. 88:1986;267-270.
15. Friedman H., Redmond D. Jr., Greenblatt D.J. Comparative pharmacokinetics of alprazolam and lorazepam in humans and in African Green Monkeys. Psychopharmacology. 104:1991;103-105.
16. Friston K.J., Ashburner J., Poline J.B., Frith C.D., Heather J.D., Frackowiak R.S.J. Spatial registration and normalisation of images. Hum. Brain Mapp. 2:1995;165-189.
17. Gallager D.W., Lakoski J.M., Gonsalves S.F., Rauch S.L. Chronic benzodiazepine treatment decreases postsynaptic GABA sensitivity. Nature. 308:1984;74-77.
18. A-receptor function. Br. J. Pharmacol. 101:1990;839-842.
19. Gandelman M.S., Baldwin R.M., Zoghbi S.S., Zea-Ponce Y., Innis R.B. Evaluation of ultrafiltration for the free fraction determination of single photon emission computed tomography (SPECT) tracers: β-CIT, IBF, and iomazenil. J. Pharm. Sci. 83:1994;1014-1019.
20. Greenblatt D.J., Shader R.I. Long-term administration of benzodiazepines: pharmacokinetic versus pharmacodynamic tolerance. Psychopharmacol. Bull. 22:1986;416-423.
21. Greenblatt D.J., Wright C.E. Clinical pharmacokinetics of alprazolam, therapeutic implications. Clin. Pharmacokinet. 24:1993;453-471.
22. Greenblatt D.J., Divoll Allen R.N., Harmatz J.S., Shader R.I. Diazepam disposition determinants. Clin. Pharmacol. Ther. 27:1980;301-312.
23. A subunit mRNA in rat brain. J. Mol. Neurosci. 2:1990;101-107.
24. Hutchinson M.A., Smith P.F., Darlington C.L. The behavioural and neuronal effects of the chronic administration of benzodiazepine anxiolytic and hypnotic drugs. Prog. Neurobiol. 49:1996;73-97.
25. A receptor subunit expression in rat neocortex during tolerance to diazepam. Mol. Pharmacol. 49:1996;822-831.
26. Innis R.B., Al-Tikriti M.S., Zoghbi S.S., Baldwin R.M., Sybirska E.H., Laruelle M.A., Malison R.T., Seibyl J.P., Zimmermann R.C., Johnson E.W., Smith E.O., Charney D.S., Heninger G.R., Woods S.W., Hoffer P.B. SPECT imaging of the benzodiazepine receptor: feasibility of in vivo potency measurements from stepwise displacements curves. J. Nucl. Med. 32:1991;1754-1761.
27. A receptor subunit mRNA concentrations following chronic lorazepam administration. Br. J. Pharmacol. 103:1991;1285-1287.
28. Kirk, R.E., 1982. Experiment Design: Procedures for the Behavioral Sciences. Brooks/Cole Publishing, Pacific Grove, CA.
29. Klotz U., Antonin K.H., Bieck T. Pharmacokinetics and plasma binding of diazepam in man, dog, rabbit, guinea pig and rat. J. Pharmacol. Exp. Ther. 199:1976;67-73.
30. 123I ]iomazenil binding to benzodiazepine receptors in nonhuman primates: II. Equilibrium analysis of constant infusion experiments and correlation with in vitro parameters J. Cereb. Blood Flow Metab. 14:1994;453-465.
31. A receptor subunit mRNA expression during tolerance to diazepam-induced cognition dysfunction. Neuropharmacology. 35:1996;1465-1473.
32. Lopez F., Miller L.G., Greenblatt D.J., Paul S.M., Shader R.I. Low-dose alprazolam augments motor activity in mice. Pharmacol. Biochem. Behav. 30:1988;511-513.
33. Lucki I., Rickels K., Geller A.M. Chronic use of benzodiazepines and psychomotor and cognitive test performance. Psychopharmacolgy. 88:1986;426-433.
34. McCormick S.R., Nielsen J., Jatlow P. Quantification of alprazolam in serum or plasma by liquid chromatography. Clin. Chem. 30:1984;1662-1665.
35. Mele L., Sagratella S., Massotti M. Chronic administration of diazepam to rats causes changes in EEG patterns and in coupling between GABA receptors and benzodiazepine binding sites in vitro. Brain Res. 323:1984;93-102.
36. Michelini S., Cassano G.B., Frare F., Perugi G. Long-term use of benzodiazepines: tolerance, dependence and clinical problems in anxiety and mood disorders. Pharmacopsychiatry. 29:1996;127-134.
37. Miller L.G., Greenblatt D.J., Barnhill J.G., Deutsch S.I., Shader R.I., Paul S.M. Benzodiazepine receptor binding of triazolobenzodiazepines in vivo: increased receptor number with low-dose alprazolam. J. Neurochem. 49:1987;1595-1601.
38. Miller L.G., Greenblatt D.J., Paul S.M., Shader R.I. Benzodiazepine receptor binding in vivo. J. Pharmacol. Exp. Ther. 240:1987;516-522.
39. Miller L.G., Greenblatt D.J., Barnhill J.G., Shader R.I. Chronic benzodiazepine administration: I. Tolerance is associated with benzodiazepine receptor downregulation and decreased gamma-aminobutyric acid receptor function. J. Pharmacol. Exp. Ther. 246:1988;170-176.
40. A receptor complex binding and function. J. Pharmacol. Exp. Ther. 246:1988;177-181.
41. Miller L.G., Woolverton S., Greenblatt D.J., Lopez F., Roy B., Shader R.I. Chronic benzodiazepine administration: IV. Rapid development of tolerance and receptor down regulation associated with alprazolam administration. Biochem. Pharmacol. 38:1989;3773-3777.
42. A receptor α subunits after flurazepam treatment. Eur. J. Pharmacol. 226:1992;335-341.
43. Ramsey-Williams V.A., Wu Y., Rosenberg H.C. Comparison of anticonvulsant tolerance, crosstolerance, and benzodiazepine receptor binding following chronic treatment with diazepam or midazolam. Pharmacol. Biochem. Behav. 48:1994;765-772.
44. Richelson E., Nelson A., Neeper R. Binding of benzodiazepines and some major metabolites at their sites in normal human frontal cortex in vitro. J. Pharmacol. Exp. Ther. 256:1991;897-901.
45. Rosenberg H.C., Chiu T.H. Tolerance during chronic benzodiazepine treatment associated with decreased receptor binding. Eur. J. Pharmacol. 70:1981;453-460.
46. Scavone J.M., Greenblatt D.J., Goddard J.E., Friedman H., Harmatz J.S., Shader R.I. The pharmacokinetics and pharmacodynamics of sublingual and oral alprazolam in the postprandial state. Eur. J. Clin. Pharmacol. 42:1992;439-443.
47. Shader R.I., Greenblatt D.J. Use of benzodiazepines in anxiety disorders. New Engl. J. Med. 13:1993;1398-1405.
48. Smith P.F., Darlington C.L. The behavioural effects of long-term use of benzodiazepine sedative and hypnotic drugs: what can be learned from animal studies? New Zealand J. Psychol. 23:1994;48-63.
49. 3H ]flunitrazepam receptor binding in rats tolerant to the effects of nitrazepam Eur. J. Pharmacol. 147:1988;7-11.
50. Talairach, J., Tournoux, P., 1988. Co-planar stereotaxic atlas of the human brain. Thieme, New York, NY.
51. Tietz E.I., Chiu T.H., Rosenberg H.C. Regional GABA/benzodiazepine receptor/chloride channel coupling after acute and chronic benzodiazepine treatment. Eur. J. Pharmacol. 167:1989;57-65.
52. Verhoeff N.P.L.G., Busemann S.E., Hengst D., Stubbs J.B., Van Royen E.A. Dosimetry of iodine-123 iomazenil in humans. Eur. J. Nucl. Med. 20:1993;580-584.
53. 123I ]iomazenil Eur. J. Pharmacol. 249:1993;43-51.
54. Woods, S.W., Charney, D.S., 1988. Benzodiazepines. In: Last, C.G., Hersen, M. (Eds.), Handbook of Anxiety Disorders. Pergamon, New York, NY.
55. USP XXIII, 1995. Sterility tests (71). In: The United States Pharmacopeia, 23rd Revision, United States Pharmacopeial Convention, Rockville, MD, pp. 1686-1690.
56. 123I ]iomzenil by iododestannylation: implications for the reaction mechanism Appl. Radiat. Isot. 45:1993;63-68.
57. 123I ]iomazenil in human and nonhuman primates Nucl. Med. Biol. Int. J. Radiat. Appendix B. 19:1992;881-888.